Drug
Therapy Committee
Theodore
Stern, MD, Interin Chair
Dena Alioto, RPh
Kate Barba, RN
Kathryn Beauchamp, RN, MSN
Theodore Benzer, MD
Kathryn Brush, RN
Margaret Clapp, MS, RPh
John Clark, MD
Nicole Devita, RPh
Jessica Dudley, MD
Robert Hallisey, MS, RPh
David Hooper, MD
Michael Langan, MD
Donald Lloyd-Jones, MD
Benjamin
Matthews, MD
Regina Melanson, PharmD, RPh
Kathleen McKibbin, MD
Carl Rosow, MD
Nina Tolkoff-Rubin, MD
Jerry Younger, MD
Editor
Barbara Irby, MS, RPh
Web Design
Ron Imperiali, RPh
Highlights from Drug Therapy Committee Meeting November 2002
Volume XII, Issue 12
December 2002
Volume XII, Issue 11
November 2002
The
MGH Influenza Vaccine Program for 2002-3
John Vetrano, RPh Senior Attending Pharmacist
Osteoporosis
at a Glance
John Vetrano, RPh Senior Attending Pharmacist
Volume XII, Issue 10
October 2002
Influenza,
Vaccines and Antivirals
Harold J. DeMonaco,
MS, Director of Drug Therapy Management
Volume XII, Issue 9
September 2002
A
Re-Evaluation of Diphenhydramine-- Could This Old Drug Be Bad for Our
Old?
Recommendations of the Drug
Therapy Committee
Volume XII, Issue 8
August 2002
How
Well Do We Manage Depression at the MGH?
We Can and Should Do Better
Recommendations of the Drug Therapy Committee
Volume XII, Issue 7
July 2002
Hormone
Replacement Therapy- What did the JAMA Study really show?
Harold J. DeMonaco, MS, Director of Drug Therapy Management
Volume XII, Issue 6
June 2002
"If
a pharmaceutical company offered to pay you money to wear a small patch
on the chest pocket of your white coat advertising their product, would
you consider it?"
Harold J. DeMonaco, MS, Director of Drug Therapy Management
Emergency
Contraceptive Choices
Harold J. DeMonaco, MS, Director of Drug Therapy Management
Volume XII, Issue 5
May 2002
Toprol
XL: Excellent Marketing Works But Costs Your Patients Money
Harold J. DeMonaco, MS, Director of Drug Therapy Management
Isn't
All Regular Insulin "Regular"?
Harold J. DeMonaco, MS, Director of Drug Therapy Management
Volume XII, Issue 4
April 2002
Postoperative
Nausea and Vomiting: Treatment Strategies
Recommendations of the Drug
Therapy Committee
Volume XII, Issue 3
March 2002
Cephalosporin
Conversion: A Moving Target
Robert K. Hallisey, Jr., MS,
RPh
Stephen B. Calderwood, MD, Infectious Disease Division, MGH
David C. Hooper, MD, Infection Control Unit, MGH
Politics,
Economics and the PPIs
Harold J. DeMonaco, M.S.,
Director of Drug Therapy Management
Volume XII, Issue
2
February 2002
FDA
Issues Black Box Warning for Droperidol:
Recommendations of the Drug Therapy Committee
Guidelines
for Therapy of Cytomegalovirus Infection
Jay A. Fishman, M.D. Associate Professor of Medicine, Harvard
Medical School Director, Transplant Infectious Disease and Compromised
Host Program, Infectious Disease Division, Massachusetts General Hospital
Volume XII, Issue 1
January 2002